Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Single Center, Comparative Dose Ranging Study of Rifaximin Vs. Placebo in the Prevention of Travelers' Diarrhea Due to Enteropathogenic Bacteria

NCT00098384 is registered in ClinicalTrials.gov with DuPont, Hurbert L., MD as lead sponsor.

NCT NCT00098384
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00098384 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Single Center, Comparative Dose Ranging Study of Rifaximin Vs. Placebo in the Prevention of Travelers' Diarrhea Due to Enteropathogenic Bacteria
Lead sponsor
DuPont, Hurbert L., MD
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2003
Completion date
September 30, 2003
Enrollment
220
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diarrhea